Tecan Group (TECN) Q1 2026 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 TU earnings summary
12 May, 2026Executive summary
Achieved 3.4% sales growth in local currencies for Q1 2026, with order entry up 6.7%.
Book-to-bill ratio remained above 1 in both business segments.
The "Rewired" program for portfolio discipline and operational excellence is progressing as planned.
Financial highlights
Q1 2026 sales grew 3.4% in local currencies compared to the same quarter last year.
Order entry increased by 6.7% in local currencies year-over-year.
2025 full-year sales were CHF 883 million (USD 1,063 million; EUR 939 million).
Outlook and guidance
2026 guidance reaffirmed: low single-digit percentage sales growth in local currencies.
Adjusted EBITDA margin expected between 15.5% and 16.5% of sales for 2026.
Medium-term targets: CHF 1 billion sales and 20% adjusted EBITDA margin by 2028.
Outlook assumes stable tariff rates and specific exchange rate forecasts (EUR/CHF 0.92, USD/CHF 0.80).
Latest events from Tecan Group
- 2025 saw sales and profit decline, but transformation targets CHF 1bn sales and 20% EBITDA by 2028.TECN
H2 202512 May 2026 - Sales and profit fell on biopharma and China weakness, but order recovery signals future growth.TECN
H1 20241 Feb 2026 - Targets above-market growth via digital innovation, cost control, and global expansion.TECN
CMD 202419 Jan 2026 - Transformation, innovation, and automation drive renewed growth and market leadership.TECN
44th Annual J.P. Morgan Healthcare Conference14 Jan 2026 - Digital innovation and modular platforms drive growth despite 2024 headwinds.TECN
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Sales growth resumed in H2 2025, with strong order entry and positive medium-term outlook.TECN
H2 2025 TU9 Jan 2026 - Sales and profit fell in 2024, but cost controls and innovation support a stable 2025 outlook.TECN
H2 202416 Dec 2025 - Q1 2025 sales declined as expected, but outlook and profitability guidance remain unchanged.TECN
Q1 2025 TU26 Nov 2025 - Q3 2025 sales rebounded, Partnering Business led growth, and full-year outlook is reaffirmed.TECN
Q3 2025 TU26 Nov 2025